Treatment records show a sharp rise in stimulant use in Oman, 2019–2024

Rapid growth of amphetamine use among treatment-seeking individuals with substance use disorders in Oman, 2019-2024: a retrospective descriptive and analytical study.

The American journal of drug and alcohol abuse • • Moderately Relevant
🤖

AI Summary

This retrospective study examined substance-use patterns and factors associated with amphetamine use among 2,902 people seeking addiction treatment in Oman from 2019 to 2024. The primary finding was a marked shift toward stimulant use: it rose from 8% in 2019 to 66% in 2024. Opiates and cannabis were also commonly reported, by 71.5% and 59.9% of participants, respectively.

The analysis found that younger age, male gender, intermediate education, and unemployment were associated with amphetamine use; these are associations, not evidence that those factors cause use. The authors say the shift supports stronger surveillance and targeted prevention. Because this was an observational study of people seeking treatment in Oman, it cannot establish causes or represent substance use among the wider population; this is an abstract-based summary, not a review of the full paper.

💡 Key Findings

1
Among treatment-seeking people in Oman, reported stimulant use increased from 8% in 2019 to 66% in 2024.
High
95%
2
Cannabis was reported by 59.9% of participants, while opiates were reported by 71.5%.
High
95%
3
Younger age, male gender, intermediate education, and unemployment were associated with amphetamine use in the adjusted analysis; the observational findings do not establish causation.
High
90%

📄 Original Abstract

Background: In Oman, emerging post-COVID-19 reports suggest a substantial shift in substance use patterns, particularly toward stimulant use among individuals seeking addiction treatment.Objectives: We analyzed substance use patterns among treatment-seeking individuals with substance use disorders (SUDs) using pooled National Registry for Addiction data from 2019 to 2024 and identified factors associated with amphetamine use.Methods: A retrospective descriptive and analytical study was conducted using anonymized registry data. Sociodemographic characteristics, substance use patterns, routes of administration, and blood-borne infections were analyzed among 2,902 individuals. Multiple logistic regression was used to identify factors associated with amphetamine use.Results: The study population was predominantly male (97.7%), young (mean age 33 ± 9 years), and Omani (98.4%). Opiates and cannabis were reported by 71.5% and 59.9% of individuals, respectively. Stimulant use increased sharply from 8% in 2019 to 66% in 2024. Injection drug use was reported by 66.0% of individuals; after adjustment for other substances, opiate use remained the dominant category associated with injection drug use, accounting for approximately 81.8% of IDU cases. In multivariable analysis, younger age (aOR = 0.96, 95% CI [0.95, 0.97], p < .001), male gender (aOR = 2.11, 95% CI [1.25, 3.67], p = .006), intermediate education (aOR = 1.28, 95% CI [1.05, 1.55], p = .014), and unemployment (aOR = 2.36, 95% CI [1.99, 2.79], p < .001) were associated with amphetamine use.Conclusions: Among treatment-seeking individuals in Oman, substance use patterns shifted rapidly toward stimulants, consistent with regional and global ATS trends, supporting strengthened surveillance and targeted prevention.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.